BDTX-1535 is a brain-penetrant and potent MasterKey inhibitor of oncogenic mutations of EGFR, including the mutations that co-occur in GBM, as well as those that commonly occur in NSCLC and those that emerge as resistance mechanisms to current-generation EGFR inhibitors.
For research use only. We do not sell to patients.
Name | BDTX-1535 |
---|---|
Iupac Chemical Name | (2E)-N-[4-[(3-Chloro-2-fluorophenyl)amino]-7-[2-[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hex-1-yl]ethynyl]-6-quinazolinyl]-4-(4-morpholinyl)-2-butenamide |
Synonyms | BDTX-1535 ; BDTX 1535 ; BDTX1535 ; |
Molecular Formula | C30H30ClFN6O2 |
Molecular Weight | 560.2103 |
Smile | O=C(NC1=CC2=C(NC3=CC=CC(Cl)=C3F)N=CN=C2C=C1C#C[C@]45CN(C)C[C@@]4([H])C5)/C=C/CN6CCOCC6 |
InChiKey | LMOVDLRMIRLIJF-TUVXKDNKSA-N |
InChi | InChI=1S/C30H30ClFN6O2/c1-37-17-21-16-30(21,18-37)8-7-20-14-26-22(29(34-19-33-26)36-24-5-2-4-23(31)28(24)32)15-25(20)35-27(39)6-3-9-38-10-12-40-13-11-38/h2-6,14-15,19,21H,9-13,16-18H2,1H3,(H,35,39)(H,33,34,36)/b6-3+/t21-,30+/m1/s1 |
CAS Number | 2607829-38-7 |
Related CAS | 2607829-38-7 |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Yellow solid |
---|---|
Purity | ≧98.0% |
Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | Refer to MSDS |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code | 2934200090 |
Targets | EGFR inhibitor |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |